Search research articles
Contact Us
Filters
Showing results (1181-1190 of 1,281) with videos related to
Page
of 129
Sort By:
The Lancet. Oncology
|
May 18, 2013
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data
Audrey Mauguen, Jean-Pierre Pignon, Sarah Burdett, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 24, 2016
A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer
David R Gandara, Natasha Leighl, Jean-Pierre Delord, et al.
Therapeutic Advances in Medical Oncology
|
December 30, 2024
Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations
Nadia Ghazali, Jamie Feng, Katrina Hueniken, et al.
British Journal of Cancer
|
February 19, 2016
Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients
Petra Martin, Carolyn J Shiau, Maria Pasic, et al.
Breast Cancer Research and Treatment
|
March 5, 2018
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics
Megan S Rice, Rulla M Tamimi, Kimberly A Bertrand, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 19, 2024
Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort
Y Li, M Wong, L Zhan, et al.
Therapeutic Advances in Medical Oncology
|
September 26, 2022
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy
Miguel Garcia-Pardo, Kasia Czarnecka, Jennifer H Law, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 25, 2020
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models
Sebastiao N Martins-Filho, Jessica Weiss, Nhu-An Pham, et al.
The Oncologist
|
April 7, 2019
The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis
Grainne M O'Kane, Jie Su, Brandon C Tse, et al.
Clinical Lung Cancer
|
May 17, 2025
Real-World Creatinine-Based Estimates of Acute and Chronic Kidney Dysfunction in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase Inhibitors
Louis Pinard, Avinash Rao Ullur, Louis Everest, et al.
Page
of 129
Search research articles
Search
Showing results (1181-1190 of 1,281) with videos related to
Sort By:
Page
of 129
The Lancet. Oncology
|
May 18, 2013
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data
Audrey Mauguen, Jean-Pierre Pignon, Sarah Burdett, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 24, 2016
A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer
David R Gandara, Natasha Leighl, Jean-Pierre Delord, et al.
Therapeutic Advances in Medical Oncology
|
December 30, 2024
Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations
Nadia Ghazali, Jamie Feng, Katrina Hueniken, et al.
British Journal of Cancer
|
February 19, 2016
Clinical impact of mutation fraction in epidermal growth factor receptor mutation positive NSCLC patients
Petra Martin, Carolyn J Shiau, Maria Pasic, et al.
Breast Cancer Research and Treatment
|
March 5, 2018
Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics
Megan S Rice, Rulla M Tamimi, Kimberly A Bertrand, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 19, 2024
Single organ metastatic sites in non-small cell lung cancer: Patient characteristics, treatment patterns and outcomes from a large retrospective Canadian cohort
Y Li, M Wong, L Zhan, et al.
Therapeutic Advances in Medical Oncology
|
September 26, 2022
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy
Miguel Garcia-Pardo, Kasia Czarnecka, Jennifer H Law, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 25, 2020
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models
Sebastiao N Martins-Filho, Jessica Weiss, Nhu-An Pham, et al.
The Oncologist
|
April 7, 2019
The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis
Grainne M O'Kane, Jie Su, Brandon C Tse, et al.
Clinical Lung Cancer
|
May 17, 2025
Real-World Creatinine-Based Estimates of Acute and Chronic Kidney Dysfunction in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase Inhibitors
Louis Pinard, Avinash Rao Ullur, Louis Everest, et al.
Page
of 129